… prohemostatic agents can counteract the anticoagulant action of DOACs in emergency
situations, when specific reversal agents are unavailable. However, specific reversal agents are …

… to 25 of the nursing staff, physicians, and pharmacists in the ICU at … Differences in sedative,
NMBA, and reversal agents use … The frequency of use of the agents based on type of hospital …

… rapid reversal agents in urgent clinical scenarios. Idarucizumab has been approved commercially
for acute reversal of … More candidate agents are in preclinical trials. It is likely that more …

… agent have any deleterious side effects of its own, will reversal of anticoagulation place the
patient at an undue risk of a thrombotic event, and will the reversal agent be expensive and …

… agents and variety of anticoagulants with different mechanisms of action, pharmacokinetics,
indications, and corresponding reversal agents increase, physicians … by hospital resources …

… /antiplatelet agents and their reversal agents in … Reversal management for each agent is
briefly mentioned in this section and discussed further in the Pharmacology of Reversal Agents …

… The type of reversal agent utilized was compared for the type of hospital, country region,
and type of ordering physician. In addition, pharmacists were asked to rank their involvement …

… pathway option that could enable earlier availability of NOAC reversal agents for the
benefit of both patients and physicians. Additional clinical studies might be recommended for …

… , especially in situations where a specific reversal agent is not available. The choice between
… , they should only be administered by physicians experienced in their use and in bleeding …

… Availability of new reversal agents for approved … hospital in order to determine the
need for a novel reversing … not reversed with protamine due to physician preference and …